CN102920829A - Drug for treating psoriasis and preparation method thereof - Google Patents
Drug for treating psoriasis and preparation method thereof Download PDFInfo
- Publication number
- CN102920829A CN102920829A CN2012104943693A CN201210494369A CN102920829A CN 102920829 A CN102920829 A CN 102920829A CN 2012104943693 A CN2012104943693 A CN 2012104943693A CN 201210494369 A CN201210494369 A CN 201210494369A CN 102920829 A CN102920829 A CN 102920829A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- medicine
- drug
- rhizoma rhei
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention discloses a drug for treating psoriasis. The drug is prepared by taking lightyellow sophora root, pricklyash peel, centipede, 10 parts of scorpion, musk, rhubarb root and rhizome, rhubarb root and rhizome honey and essential balm as raw materials. The drug can be used for preparing various clinically used medicaments. In the prescription, the raw materials are reasonable in compatibility, so the drug can clear away heat and dry damp, cool blood and remove toxicity and have better curative effect on psoriasis. Clinical test results prove that the drug has obvious effect, does not have toxic or side effect and is safe and reliable in clinical application.
Description
Technical field
The present invention relates to a kind of psoriatic medicine for the treatment of, specially refer to a kind of psoriatic medicine for the treatment of of the preparation take Chinese herbal medicine as raw material, the invention still further relates to the preparation method of this medicine.
Background technology
As everyone knows, psoriasis is commonly called as psoriasis, is a kind of common the chronic of characteristic skin lesion that have, and easily the inflammatory skin of recurrence is sick, covers the silvery white squama of multilamellar as feature on red pimple or speckle.The cause of disease and the sick mechanism of sending out of primary disease are not yet drawn sure conclusion so far abroad.Motherland's medical science is thought primary disease by invading in the exopathogen, internal injury caused by excess of seven emotions, the taste inside and outside combined pathogens such as become estranged, and heat is stopped up due to the blood network.At present, treat psoriatic medicine and totally be divided into Western medicine and Chinese medicine two classes, the Corticosterone hormone is adopted in the Western medicine external more, and life-time service easily produces dependency, and the toxic side effect generation, in addition, also have a lot of Chinese medicines, but effect can not be satisfactory mostly.
Summary of the invention
The present invention aims to provide that a kind of therapeutic effect is good, cost is low, the medicine of the psoriatic medicine for the treatment of of non-evident effect and preparation method thereof.
The preparation method that this medicine is provided is another goal of the invention of the present invention.
Medicine of the present invention is to be made by the raw material of following quality proportioning:
Radix Sophorae Flavescentis 15-25 part, Pericarpium Zanthoxyli 10-20 part, Scolopendra 5-15 part, Scorpio 5-15 part, Moschus 2-7 part, Radix Et Rhizoma Rhei 5-15 part, Radix Et Rhizoma Rhei Mel 5-15 part, menthocamphorate 15-25 part.
The further quality proportioning of medicine each component of the present invention is:
20 parts of Radix Sophorae Flavescentiss, 15 parts in Pericarpium Zanthoxyli, 10 parts of Scolopendras, 10 parts of Scorpios, 4 parts in Moschus, 10 parts of Radix Et Rhizoma Rhei, 10 parts of Radix Et Rhizoma Rhei Mel, 20 parts of menthocamphorates.
Medicine of the present invention can be made the external used medicine of clinical acceptance.
The concrete preparation method of medicine of the present invention is as follows:
With above-mentioned Radix Sophorae Flavescentis, Pericarpium Zanthoxyli, Scolopendra, Scorpio, Moschus, Radix Et Rhizoma Rhei according to described ratio of weight and number mix homogeneously after, be ground into fine powder, then with menthocamphorate, Radix Et Rhizoma Rhei Mel furnishing pasty state, make the external used medicine of clinical acceptance.
In the prescription of the present invention, the Radix Sophorae Flavescentis heat clearing and damp drying, parasite killing is controlled skin pruritus; Pricklyash peel insecticidal itching relieving; The Scolopendra dispersing pathogen accumulation, collateral dredging relieves dizziness, high fever, infantile convulsions, epilepsy, etc.; The Scorpio dispelling wind and removing obstruction in the collateral, detoxifcation; The Moschus promoting blood circulation to restore menstrual flow, mass dissipating and swelling eliminating; The Radix Et Rhizoma Rhei heat and toxic materials clearing away, clearing away heat-fire, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation; The sterilization of Radix Et Rhizoma Rhei Mel, the nutrition wound surface accelerates wound repair; The menthocamphorate heat radiation is antipruritic, antiinflammatory.Between each medicine of prescription addition complementation and synergism are arranged, removing blood stasis can be treated all kinds psoriasis preferably.
During treatment, this medicine was taken for three times morning, noon, late dividing.
The present invention is the experience that the inventor uses the clinical more than ten years, through repeatedly research, progressively improve, a kind of curative effect of last success is treated psoriatic medicine preferably, for showing that medicine of the present invention is to psoriatic therapeutic effect, the present invention uses the patient of this medicine to carry out clinical observation to 102 examples, and patient's 97 examples of selecting to have comparability are organized in contrast.Treatment group patient uses this medicine, and the pasty state ointment is coated in clean affected part, uses immobilization with adhesive tape, keeps 3-4 days, bad outer being coated with once of effect, this place's skin lesion generally can be died away, and is difficult for recurrence, the matched group patient uses conventional external used medicine, treats after 10 days, and therapeutic outcome sees Table 1
Table 1 treatment group and treatment of control group be synopsis as a result
| ? | Cure | Effectively | Cure rate | Effective percentage |
| Treatment group | 94 | 99 | 92.16% | 97.06% |
| Matched group | 23 | 35 | 23.71% | 36.08% |
Treatment group is compared matched group and is had higher cure rate and effective percentage, thinks thus, and Drug therapy psoriasis of the present invention has preferably effect, and observes through treatment, uses medicine of the present invention any toxic and side effects not occur.
The specific embodiment
Below in conjunction with embodiment the present invention is described in further detail, but does not consist of any limitation of the invention.
Embodiment 1
Prepare raw material according to following weight:
Radix Sophorae Flavescentis 16kg, Pericarpium Zanthoxyli 11 kg, Scolopendra 6 kg, Scorpio 6 kg, Moschus 6 kg, Radix Et Rhizoma Rhei 14 kg, Radix Et Rhizoma Rhei Mel 14 kg, menthocamphorate 25 kg.
With above-mentioned Radix Sophorae Flavescentis, Pericarpium Zanthoxyli, Scolopendra, Scorpio, Moschus, Radix Et Rhizoma Rhei according to described ratio of weight and number mix homogeneously after, be ground into fine powder, then with menthocamphorate, Radix Et Rhizoma Rhei Mel furnishing pasty state, make the external used medicine of clinical acceptance.
Embodiment 2
Prepare raw material according to following weight:
Radix Sophorae Flavescentis 24 kg, Pericarpium Zanthoxyli 19 kg, Scolopendra 14 kg, Scorpio 14 kg, Moschus 2 kg, Radix Et Rhizoma Rhei 6kg, Radix Et Rhizoma Rhei Mel 6 kg, menthocamphorate 16 kg.
With above-mentioned Radix Sophorae Flavescentis, Pericarpium Zanthoxyli, Scolopendra, Scorpio, Moschus, Radix Et Rhizoma Rhei according to described ratio of weight and number mix homogeneously after, be ground into fine powder, then with menthocamphorate, Radix Et Rhizoma Rhei Mel furnishing pasty state, make the external used medicine of clinical acceptance.
Claims (3)
1. treat psoriatic medicine for one kind, it is characterized in that described medicine is to be made by the raw material of following quality proportioning:
Radix Sophorae Flavescentis 15-25 part, Pericarpium Zanthoxyli 10-20 part, Scolopendra 5-15 part, Scorpio 5-15 part, Moschus 2-7 part, Radix Et Rhizoma Rhei 5-15 part, Radix Et Rhizoma Rhei Mel 5-15 part, menthocamphorate 15-25 part.
2. the psoriatic medicine for the treatment of according to claim 1 is characterized in that described medicine is to be made by the raw material of following quality proportioning:
20 parts of Radix Sophorae Flavescentiss, 15 parts in Pericarpium Zanthoxyli, 10 parts of Scolopendras, 10 parts of Scorpios, 4 parts in Moschus, 10 parts of Radix Et Rhizoma Rhei, 10 parts of Radix Et Rhizoma Rhei Mel, 20 parts of menthocamphorates.
3. the preparation method of claim 1 or the psoriatic medicine of 2 described treatments, be with above-mentioned Radix Sophorae Flavescentis, Pericarpium Zanthoxyli, Scolopendra, Scorpio, Moschus, Radix Et Rhizoma Rhei according to described ratio of weight and number mix homogeneously after, be ground into fine powder, then with menthocamphorate, Radix Et Rhizoma Rhei Mel furnishing pasty state, make the external used medicine of clinical acceptance.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104943693A CN102920829A (en) | 2012-11-28 | 2012-11-28 | Drug for treating psoriasis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104943693A CN102920829A (en) | 2012-11-28 | 2012-11-28 | Drug for treating psoriasis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102920829A true CN102920829A (en) | 2013-02-13 |
Family
ID=47635854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104943693A Pending CN102920829A (en) | 2012-11-28 | 2012-11-28 | Drug for treating psoriasis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102920829A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393772A (en) * | 2013-08-22 | 2013-11-20 | 王爱枝 | Medicine for treating psoriasis, and preparation method of medicine |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1049789A (en) * | 1990-02-24 | 1991-03-13 | 郭桂芹 | The manufacture method of musk-toad bolus |
| US20050054036A1 (en) * | 2001-08-01 | 2005-03-10 | David Bates | Growth factor isoform |
| WO2006018844A1 (en) * | 2004-08-16 | 2006-02-23 | Medical Research Fund At The Tel Aviv Sourasky Medical Center | Method and composition for modulation of systemic inflammatory responses syndrome (sirs) |
| CN101181376A (en) * | 2007-11-15 | 2008-05-21 | 王永霞 | Medicine for curing psoriasis and producing method thereof |
| CN101940652A (en) * | 2010-09-01 | 2011-01-12 | 王献臣 | Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus |
| CN102784343A (en) * | 2012-09-01 | 2012-11-21 | 李瑞吉 | External use traditional Chinese medicine preparation for treating psoriasis |
-
2012
- 2012-11-28 CN CN2012104943693A patent/CN102920829A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1049789A (en) * | 1990-02-24 | 1991-03-13 | 郭桂芹 | The manufacture method of musk-toad bolus |
| US20050054036A1 (en) * | 2001-08-01 | 2005-03-10 | David Bates | Growth factor isoform |
| WO2006018844A1 (en) * | 2004-08-16 | 2006-02-23 | Medical Research Fund At The Tel Aviv Sourasky Medical Center | Method and composition for modulation of systemic inflammatory responses syndrome (sirs) |
| CN101181376A (en) * | 2007-11-15 | 2008-05-21 | 王永霞 | Medicine for curing psoriasis and producing method thereof |
| CN101940652A (en) * | 2010-09-01 | 2011-01-12 | 王献臣 | Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus |
| CN102784343A (en) * | 2012-09-01 | 2012-11-21 | 李瑞吉 | External use traditional Chinese medicine preparation for treating psoriasis |
Non-Patent Citations (1)
| Title |
|---|
| 卢传坚等: "《皮肤病治疗调养全书》", 28 February 2009, 化学工业出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393772A (en) * | 2013-08-22 | 2013-11-20 | 王爱枝 | Medicine for treating psoriasis, and preparation method of medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101822739A (en) | Medicine for treating burn and preparation method thereof | |
| CN102698132B (en) | External used medicine for treating tumor | |
| CN102920829A (en) | Drug for treating psoriasis and preparation method thereof | |
| CN102988914A (en) | Traditional Chinese medicine formulation for treating gonarthromeningitis | |
| CN102397532A (en) | Compound propolis composition for treating duckling parvovirus disease and preparation method thereof | |
| CN101926868B (en) | External traditional Chinese medicine for preventing and treating phlebitis caused by chemotherapeutic medicines | |
| CN102920827A (en) | Drug for treating seborrheic dermatitis and preparation method thereof | |
| CN103768272A (en) | Traditional Chinese medicine for treating folliculitis | |
| WO2017220045A1 (en) | Formulation treating sprains and contusions | |
| CN102961487B (en) | Compound combination made from pure traditional Chinese medicines and used for treating henpox and preparation method of combination | |
| CN103690813B (en) | A kind of external traditional Chinese medicinal application for the treatment of radiation dermatitis | |
| CN102764275B (en) | A kind of external application Chinese medicine for the treatment of tumor and preparation method thereof | |
| CN102335416A (en) | Compound Chinese medicinal composition for treating hog cholera and preparation method thereof | |
| CN102380072B (en) | Externally applied cold wash traditional Chinese medicine composition for activating blood and reliving pain and application thereof | |
| CN101797315B (en) | Traditional Chinese medicine composition capable of treating various skin diseases | |
| CN101199633B (en) | Paste medicament for treating folliculitis | |
| CN104056122A (en) | External traditional Chinese medicine ointment for treating electrical injury | |
| CN103393772A (en) | Medicine for treating psoriasis, and preparation method of medicine | |
| CN101332261B (en) | External medicine for treating furunculosis | |
| CN104107292A (en) | Traditional Chinese medicine preparation used for treating hyperosteogeny, and preparation method and application thereof | |
| CN103054962B (en) | Compound bee-glue composition for the treatment of domestic animal arthritis disease and preparation method thereof | |
| CN103127274A (en) | All-season burn and scald medicine for seasons | |
| CN101612241A (en) | A kind of medicine for the treatment of scald and preparation method thereof | |
| CN102397473B (en) | Composite propolis composition for treating gosling plague and preparation method thereof | |
| CN103127465A (en) | Chinese medicament for treating mammary gland hyperplasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130213 |